Your browser doesn't support javascript.
loading
Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial.
Hose, Dirk; Beck, Susanne; Salwender, Hans; Emde, Martina; Bertsch, Uta; Kunz, Christina; Scheid, Christoph; Hänel, Mathias; Weisel, Katja; Hielscher, Thomas; Raab, Marc S; Goldschmidt, Hartmut; Jauch, Anna; Moreaux, Jérôme; Seckinger, Anja.
Afiliação
  • Hose D; Labor für Myelomforschung, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Beck S; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Salwender H; Labor für Myelomforschung, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Emde M; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Bertsch U; Department of Internal Medicine II, Asklepios Klinik Altona, Hamburg, Germany.
  • Kunz C; Labor für Myelomforschung, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Scheid C; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Hänel M; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Weisel K; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany.
  • Hielscher T; Department I of Internal Medicine, University of Cologne, Cologne, Germany.
  • Raab MS; Department of Internal Medicine III, Klinikum Chemnitz GmbH, Chemnitz, Germany.
  • Goldschmidt H; Department of Hematology, Oncology and Immunology, University of Tübingen, Tübingen, Germany.
  • Jauch A; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany.
  • Moreaux J; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Seckinger A; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
J Hematol Oncol ; 12(1): 65, 2019 06 26.
Article em En | MEDLINE | ID: mdl-31242924

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Plasmócitos / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Plasmócitos / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha